Top Institutions in Ophthalmology and Gene Therapy
Institutions leading in IRD research and gene therapy have extensive clinical programs in inherited retinal diseases, conduct pioneering gene therapy trials including optogenetics, and have strong translational research bridging molecular genetics and clinical ophthalmology.
-
#1
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is a global leader in retinal disease research and gene therapy clinical trials, including pioneering work in optogenetics and inherited retinal diseases.
Key Differentiators
- Ophthalmology
- Gene Therapy
- Retinal Diseases
-
#2
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is consistently ranked among the top ophthalmology centers with a strong focus on inherited retinal diseases and active participation in gene therapy clinical trials.
Key Differentiators
- Ophthalmology
- Retinal Diseases
- Gene Therapy
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute has a robust inherited retinal disease program with a focus on molecular genetics and gene therapy development, including optogenetic approaches.
Key Differentiators
- Ophthalmology
- Genetics
- Gene Therapy
-
#4
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF has a leading ophthalmology department with active research and clinical trials in inherited retinal diseases and emerging gene therapies including optogenetics.
Key Differentiators
- Ophthalmology
- Gene Therapy
- Retinal Diseases
-
#5
Moorfields Eye Hospital and UCL Institute of Ophthalmology
London, N/A
Moorfields and UCL are internationally recognized for their research in inherited retinal diseases and gene therapy, including early optogenetics clinical studies.
Key Differentiators
- Ophthalmology
- Gene Therapy
- Retinal Diseases
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







